Source link : https://www.newshealth.biz/health-news/could-innate-immune-dysfunction-drive-lupus/
An investigational Toll-like receptor (TLR) antagonist was effective in reducing biomarkers and clinical symptoms of systemic lupus erythematosus (SLE) in a pilot trial, evidence that the innate immune system may hold the key to lupus pathophysiology. Twelve weeks of treatment with a bivalent agent called E6742 that targets TLR-7 and TLR-8 led to improvements in […]
Author : News Health
Publish date : 2024-04-29 18:36:02
Copyright for syndicated content belongs to the linked Source.